Insider Shareholders with Direct Ownership of Maze Therapeutics, Inc. (MAZE)
This section provides a comprehensive overview of the insiders with direct ownership of Maze Therapeutics, Inc. (MAZE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Maze Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 5,762,788 | 1,600,000 | 4,473,958 | 2 |
Nov 04, 2025
Reduced 26.34%
|
|
| 31,013 | 28,423 | 31,113 | 3 |
Nov 19, 2025
Added 4.57%
|
|
|
Amy Bachrodt
SVP, Finance |
20,000 | 20,000 | 12,965 | 6 |
Jan 02, 2026
Reduced 16.68%
|
|
Atul Dandekar
CSBO |
72,500 | 72,500 | 10,503 | 4 |
Dec 30, 2025
Reduced 0.94%
|
| 29,413 | 29,413 | 0 | 4 |
Jan 07, 2026
Reduced 100.0%
|
|
| 0 | 20,744 | 0 | 1 |
Sep 15, 2025
Reduced 100.0%
|
|
|
Harold Bernstein
President, R&D & CMO |
75,000 | 75,000 | 0 | 8 |
Jan 07, 2026
Reduced 100.0%
|